International Journal of Blood Research and Disorders is a peer-reviewed publication in the field of blood research. It focuses on all aspects of hematology including blood cells, hematologic diseases, blood hemostatic mechanisms, hemato-oncology, immunology, and transfusion medicine. It also focuses on all aspects of the prevention and therapy of blood disorders.

International Journal of Blood Research and Disorders aims to publish original articles, research, reviews, case reports, short communications, commentaries etc., layering the spectrum of clinical and laboratory hematological practice and research. The classification terms include but not limited to Anemia, Platelet disorders, Eosinophilic disorders, Leukemia, Myeloma, Coagulation disorders, blood Transfusion, sepsis.

International Journal of Blood Research and Disorders ensures the faster publication of high-quality articles with the support of its eminent Editorial board members. Two independent review comments followed by editor's decision will be considered to publish the article. IJBRD is a permanent archive of information on Blood research, disorders and therapeutics which under open access category provides its global readers with free access to its content, thus serving the scientific community.

 
Journal Information

Title: International Journal of Blood Research and Disorders

ISSN: 2469-5696

Editor-in-chief: Preet M Chaudhary

NLM title abbreviation: Int J Blood Res Disord

ISO abbreviation: Int J Blood Res Disord

Other titles: IJBRD

Category: Human Physiology

DOI: 10.23937/2469-5696

Peer review: Double blind

Review speed: 3 weeks

Fast-track review: 10 days

Publication format (s): Electronic and print

Publication policy: Open Access; COPE guide

Publication type(s): Periodicals

Publisher: ClinMed International Library

Country of publication: USA

Language: English

Contact email: contact@clinmedjournals.org

 
Articles Search by   Keyword   |   Journal title   |   Author name   |   DOI

 

 Open Access DOI:10.23937/2469-5696/1410033

The Results of the Single Center Pilot Randomized Russian Clinical Trial of Mesenchymal Stromal Cells in Severe Neutropenic Patients with Septic Shock (RUMCESS)

Gennadiy Galstyan, Polina Makarova, Elena Parovichnikova, Larisa Kuzmina, Vera Troitskaya, Eduard Gemdzhian and Valeriy Savchenko

Article Type: Original Article | First Published: October 12, 2018

To investigate the safety of the of bone marrow-derived human multipotent mesenchymal stromal cells (MMSCs) administration in neutropenic patients with septic shock. Mesenchymal stromal cells (MMSCs) may represent a promising cell-based therapy of sepsis. MMSCs, activated by lipopolysaccharide or tumor necrosis factor-α, reprogram macrophages by releasing prostaglandin E2. Prostaglandin E2 acts on the macrophages through the EP2 and EP4 receptors and stimulates the production and release of an ...
 

 Open Access DOI:10.23937/2469-5696/1410032

Expression of Foxp3 and Rorc Genes in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Impact in the Development of Acute and Chronic Graft-Versus-Host Disease

Camila Marca de Veiga Cabral, Walter Moises Tobias Braga, Adriano de Moraes Arantes, Jose Salvador Rodrigues de Oliveira, Gisele Wally Braga Colleoni and Fabio Rodrigues Kerbauy

Article Type: ORIGINAL ARTICLE | First Published: September 07, 2018

The aim of this study is to characterize Treg (FOXP3) and Th17 (RORC)-related genes in patients who underwent hematopoietic cell transplantation (HCT) and correlate them with graft-versus-host disease (GVHD) onset and patients' outcome. Fifty-one patients undergoing allogeneic HCT from matched related donors (MRD) were studied. Samples were collected before HCT, at acute (aGVHD) or chronic GVHD (cGVHD) onset, and 90 days post-HCT for those who di...
 

 Open Access DOI:10.23937/2469-5696/1410031

Lenalidomide Plus Dexamethasone is an Active Rescue Treatment for Myeloma with Severe Renal Impairment Failing to Bortezomib-Based Induction Therapy

Giuseppe Mele and Domenico Pastore

Article Type: Case Reports & Case Series | First Published: July 12, 2018

Patients with relapsed/refractory Multiple Myeloma (rrMM) and End Stage Renal Disease (ESRD) requiring hemodialysis must receive lenalidomide at a dosage of 5 mg daily on days 1-21 of repeated 28-day cycles, due to substantial elimination via the kidneys. Unfortunately, despite dose reduction, severe adverse events occur with a high frequency. Therefore, lenalidomide is recommended mainly in patients with mild-to-moderate renal impairment....
 

 Open Access DOI:10.23937/2469-5696/1410030

Benign Lymphadenopathy Presented in a Malignant Pathway - A Rare Case of Proteinaceous Lymphadenopathy

Md Serajul Islam and Pavel Kotoucek

Article Type: Case Report | First Published: June 30, 2018

Proteinaceous lymphadenopathy is a rare non-specific lymph node changes incidence of which increases with age. This condition is usually associated with hypergammaglobulinemia or rheumatological conditions. However, this condition can also be due to unknown aetiology as we are presenting a case where no underlying case was found. It may affect nodal function, and rarely may it calcify. Histopathologist needs to be vigilant of this condition as ly...
 

 Open Access DOI:10.23937/2469-5696/1410029

Multiple Myeloma Associated with Dermatomyositis: A Short Report and Mini-Review

Md Serajul Islam and Pavel Kotoucek

Article Type: Research Article | First Published: June 20, 2018

Multiple myeloma (MM) is characterized by the neoplastic proliferation of plasma cell clones that produce monoclonal immunoglobulin. Dermatomyositis (DM), and to a lesser extent polymyositis (PM), carry a higher risk of cancer than that of the general population as demonstrated by several studies with the prevalence being 32% and 15% for DM and PM respectively. The mechanism underlying the association between idiopathic inflammatory myopathies (IIM) and malignancies remains unclear....
 

 Open Access DOI:10.23937/2469-5696/1410028

Zika Induced Meningoencephalitis in a Ruxolitinib Treated Patient with Secondary Myelofibrosis

Ahmad Al Ghoche, Jean Pegliasco, Jessica Anne-Marie-Sainte, Julien Cuziat, Lucas Meyer, Fatiha Najioullah, Jean Côme Meniane and Samy Chraïbi

Article Type: Case Report | First Published: October 28, 2017

We describe here the first case of a patient with post-ET myelofibrosis treated with ruxolitinib at French West Indies complicated with zika induced meningoencephalitis. Patient presented with fever, confusion along with conjunctivitis, diffuse joints pain and skin rash. PCR was positive for Zika virus in blood, urine and cerebrospinal fluid. Diagnosis of Zika induced meningoencephalitis was confirmed....
 

 Open Access DOI:10.23937/2469-5696/1410027

Interstitial Deletion of Chromosome 9q in Therapy-Related Acute Promyelocytic Leukemia with Pathognomonic t(15;17) in a Patient Exposed to Radioactive Iodine

Poorva Bindal, Heenam Goel, Alexei Shimanovsky, Joseph M Ryan, Jeffrey S Wasser and Enrique Ballesteros

Article Type: Case Report | First Published: September 29, 2017

The incidence of therapy-related Acute Promyelocytic Leukemia (t-APL) has been steadily rising. Radioactive Iodine (RAI) has emerged as a potential leukemogenic insult. Translocation involving the Retinoic Acid Receptor-alpha (RAR-alpha, RARa) gene on chromosome 17 and the Promyelocytic Leukemia (PML) gene on chromosome 15....
 

 Open Access DOI:10.23937/2469-5696/1410026

Bone Marrow Necrosis: An Unusual Misdiagnosed Serious Complication

Georges El Hachem

Article Type: Literature Review | First Published: July 31, 2017

Bone Marrow Necrosis (BMN) is an uncommon syndrome characterized by destruction of hematopoietic tissue with preservation of the bone. It presents as localized or diffuse generalized process. Many underlying diseases can lead to marrow necrosis: most commonly malignancies and rarely sickle cell disease....
 

 Open Access DOI:10.23937/2469-5696/1410025

Polycomb Proteins in Hematopoiesis and Hematologic Malignancie

Jie Li

Article Type: Review Article | First Published: March 20, 2017

In recent years, the Polycomb group (PcG) of proteins has been revealed to be involved in the regulation of hematologic stem cell function and differentiation and have been broadly linked to hematologic malignancies. Polycomb proteins are histone modifiers that contain two multi-protein complexes: Polycomb Repressive Complex 1 and 2 (PRC1 and PRC2)....
 

 Open Access DOI:10.23937/2469-5696/1410024

Successful Treatment of a Primary Cervical Diffuse Large B-cell Lymphoma with Rituximab-CHOP Immunochemotherapy

Diaz De-La-Noval B, Hernandez Gutierrez A, Zapardiel I, De-Santiago Garcia J and Diestro Tejeda

Article Type: Case Report | First Published: August 30, 2016

The incidence of Non-Hodgkin's Lymphoma (NHL) has been increasing in recent decades, the prevalence of extranodal-NHL is about 30 to 50% of all NHL patients. Primary Large B-cell extranodal lymphoma of the cervix is a very rare disease, 0.008% of all cervical tumors. The Diffuse large B-cell lymphoma (DLBCL) is the most common extranodal lymphoid neoplasm in around 25% of all NHL....
 

 Open Access DOI:10.23937/2469-5696/1410023

Polycythemia Vera with High Erythropoietin Level: Case Report

Rami Nassabein, Mariam al khatib, Marie Helen Abbas, Marie youssef, Daniel Amer and Jaafar Wazni

Article Type: Case Report | First Published: August 30, 2016

Polycythemia Vera (PV) is a myeloproliferative disorder of bone marrow stem cells characterized by erythrocytosis. Elevated erythropoietin level strongly indicates secondary erythrocytosis and excludes PV diagnosis. However, patients with PV who co-present with Budd-Chiari syndrome (BCS) have been documented with elevated serum erythropoietin levels provided that JAK2 mutation is positive....
 

 Open Access DOI:10.23937/2469-5696/1410022

First Haploidentical Transplant in Peru in Pediatric Patient with Bilineal Leukemia

Mariela Del Carmen Moreno, Cinthia Palacios and Yessenia Cruz

Article Type: Case Report | First Published: August 01, 2016

Bilineal leukemia is a very rare health condition, especially in pediatric patients; it is associated with poor prognosis, even without uniformity therapeutic criteria. Hereby, we present a 4-year-old boy, who debuted as T-cell lymphoblastic lymphoma, he initially received treatment induction, which was unanswered, further studies showed evidence of being bilinear leukemia (T-AML M5). He continued the AML induction therapy followed by four consol...
 

 Open Access DOI:10.23937/2469-5696/1410021

Significance of sCD86 Levels in Acute Myelogenous Leukemia Patients: An Egyptian Study

Naglaa M Hassan, Nevin M Al-azhary and Marwa M Hussein

Article Type: Research Article | First Published: May 28, 2016

The aim of the study is to assess the level of soluble CD86 (sCD86) in patients with de novo AML and to compare them with a normal control group to determine any possible role with prognosis and clinical outcome, as the significance of sCD86 in hematologic malignancies is still controversial....
 

 Open Access DOI:10.23937/2469-5696/1410020

Chronic Use of Adalimumab as Potential Cause of Severe Thrombocytopenia in Psoriatic Arthritis Patient: The Need for Regular Monitoring of Cytopenias

Viviane Chaves Pereira, Karoline Honorato Costa and Leonardo Rodrigues de Oliveira

Article Type: Case Report | First Published: May 28, 2016

Although they are rare, severe hematologic adverse effects are described and may be fatal. The current study describes the case of a patient presenting psoriatic arthritis, and under prolonged treatment with adalimumab. His condition worsened due to severe acute thrombocytopenia and severe hemorrhagic manifestations. Adalimumab was considered to be the probable cause of the thrombocytopenia and, therefore, its use was discontinued. The treatment ...
 

 Open Access DOI:10.23937/2469-5696/1410019

In vitro Influence of Fibrinogen and Factor XIII on Viscoelastic Characteristics of Clot Formation under Hypothermia and Acidosis

DA Ammon, H Andruszkow, L Sieg, M Wilhelmi, CF Weber, N Rahe-Meyer and AA Hanke

Article Type: Research Article | First Published: November 27, 2015

Hypothermia and acidosis are risk factors for coagulopathy during trauma. We investigated influence of fibrinogen and factor XIII on whole blood coagulation under hypothermia and acidosis in an In vitro model. Fibrinogen, but not FXIII improved coagulation significantly. Furthermore, combined administration of fibrinogen and FXIII did not show differences to administration of fibrinogen alone....
 

 Open Access DOI:10.23937/2469-5696/1410018

The Management of Mucositis of Pediatric Hematopoietic Stem-Cell Transplantation

CIFTCIOGLU Sule and EFE Emine

Article Type: Perspective | First Published: September 23, 2015

Hematopoietic stem-cell transplantation (HSCT) is used primarily for hematologic and lymphoid cancers but also for many other disorders. Autologous HSCT (in which stem cells are derived from the patient) is mainly used to treat chemosensitive malignancies. Allogeneic HSCT (in which the stem cells are derived from a donor) is often the preferred treatment option, particularly in patients with acute leukaemia. Oral complications are a significant c...
 

 Open Access DOI:10.23937/2469-5696/1410017

The Evaluation of Serum Protein and Serum Immunofixation Electrophoresis Results in Patients with Monoclonal and Polyclonal Gammopathy: A Single Center Experience

Koksal Deveci, Serdal Korkmaz, Enver Sancakdar, Duygu Acibucu, Filiz Alkan, Hatice Terzi and Mehmet Sencan

Article Type: Research Article | First Published: September 17, 2015

A monoclonal gammopathy is defined as the electrophoretically and antigenically homogeneous protein product of a single clone of B lymphocytes and/or plasma cells that has proliferated beyond the constraints of normal control mechanisms. Monoclonal gammopathies are detected in serum and/or urine from individuals with a wide variety of neoplastic, potentially neoplastic, neurological and infectious conditions....
 

 Open Access DOI:10.23937/2469-5696/1410016

The Levels of PAI-1, Urokinase uPA, Thrombomodulin and TFPI in Essential Thrombocythemia

Oktay Bilgir, Ferda Bilgir, Mehmet Calan and Giray Bozkaya

Article Type: Research Article | First Published: September 05, 2015

Generally, ET is a myeloproliferative disorder characterized by persistent peripheral thrombocytosis and abnormal megakaryocytic proliferation in the bone marrow. ET is a rare cause of thrombocytosis and may be associated with both venous and arterial thrombosis in 10-75% of cases, depending largely on the study and whether vasomotor symptoms are included in thrombotic manifestations....
 

 Open Access DOI:10.23937/2469-5696/1410015

The Role of Positron Emission Tomography Imaging in the Risk-Adapted Treatment of Stage I-II Hodgkin's Lymphoma - A Retrospective Analysis

Tom Rider, John Jones, John Brewin, Gillian Horne, Jack Wills, Hannah Barton, Kevin Boyd, Timothy Corbett, Sabina Dizdarevic and Timothy Chevassut

Article Type: Research Article | First Published: July 09, 2015

Early stage Hodgkin's Lymphoma (HL) has excellent outcomes and recent research has focused on minimising treatment-related toxicities. However, the role of 18F-florodeoxyglucose positron emission tomography (FDG PET) imaging in this setting is not fully determined. We retrospectively calculated overall survival (OS) and relapse free survival (RFS) in stage I-II HL when radiotherapy was omitted if post-chemotherapy FDG PET imaging was negative....
 

 Open Access DOI:10.23937/2469-5696/1410014

Pediatric B-cell Non-Hodgkin Lymphoma: 21-year Experience with FAB-LMB Protocols in a Single Institute in Greece

Apostolos Pourtsidis, Marina Servitzoglou, Margarita Baka, Despina Bouhoutsou, Maria Varvoutsi, Dimitrios Doganis, Katherine Strantzia-Michail and Helen Kosmidis

Article Type: Research Article | First Published: May 10, 2015

Aims and background: Our objective was to analyze the clinical and demographic characteristics of children with B-cell lymphoma treated in a single center over the last two decades. Methods: Data was collected by a retrospective review of the charts of all 76 patients treated to our unit, from 1990 to 2010, with FAB LMB 89, 96 protocols and 2003 modifications....
 

 Open Access DOI:10.23937/2469-5696/1410013

Fetal and Neonatal Alloimmune Thrombocytopenia: Advances in Laboratory Diagnosis and Management

Hacene Brouk and Hanifa Ouelaa

Article Type: Review Article | First Published: April 30, 2015

Fetal and neonatal alloimmune thrombocytopenia (F/NAIT), caused by fetomaternal mismatch for human platelet (PLT) alloantigens (HPAs), is the commonest cause of severe thrombocytopenia in term neonates and is analogous to the fetal/neonatal anaemia caused by haemolytic disease of the newborn (HDN). The most feared complication of this syndrome is the occurrence of intracranial hemorrhage leading to death or neurological sequels....
 

 Open Access DOI:10.23937/2469-5696/1410012

The Comparison between Microhematocrit and Automated Methods for Hematocrit Determination

Gebrewahd Gebretsadkan, Kebede Tessema, Henock Ambachew and Misganaw Birhaneselassie

Article Type: Research Article | First Published: April 01, 2015

Hematocrit is a test that measures a percentage of blood that is comprised of red blood cell. This is often referred to as packed cell volume (PCV) or erythrocyte volume fraction. It is considered as an integral part of a person's complete blood count, along with hemoglobin concentration, white blood cell count and platelet counts....
 

 Open Access DOI:10.23937/2469-5696/1410011

Hemolytic Anemia in Alcohol-Induced Liver Disease: A Case Report on Zieve's Syndrome

Shefali Nath and Joshua R Peck

Article Type: Case Report | First Published: March 26, 2015

We report a case of Zieve's syndrome in a patient with a longstanding history of alcohol abuse admitted for acute alcoholic hepatitis. Zieve's syndrome is defied as the triad of hemolytic anemia, hypertriglyceridemia, and jaundice in patients with known liver disease. It is an uncommon diagnosis, but is an important one to consider in patients with known liver disease admitted with these constellation of signs and symptoms....
 

 Open Access DOI:10.23937/2469-5696/1410010

Lenalidomide in patients with Relapsed or Refractory HTLV-1 Related Adult T cell Leukemia/Lymphoma (ATLL)

Adrienne A. Phillips, Jalanni Giddings, Shing M. Lee and Steven M. Horwitz

Article Type: Case Report | First Published: March 21, 2015

Adult T-cell Leukemia/Lymphoma (ATLL) is resistant to chemotherapy and the acute and lymphomatous subtypes of disease have a dismal prognosis. There is no standard therapy for relapsed or refractory disease in Western countries and new agents are being explored. Lenalidomide is an immunomodulatory agent with promising activity in hematologic malignancies, including non-Hodgkin's lymphoma and represents a novel therapeutic option. ...
 

 Open Access DOI:10.23937/2469-5696/1410009

The Use of Diffusion Weighted Imaging in the Diagnosis of Intraocular Relapse of Acute Lymphoblastic Leukemia: A Case Report

Kee Kiat Yeo, Jonathan G. Murnick, Marijean M. Miller and Anne L. Angiolillo

Article Type: Case Report | First Published: February 23, 2015

Intraocular relapse of Acute Lymphoblastic Leukemia (ALL) is rare. Prompt diagnosis and treatment can minimize vision loss. We report a case of a young girl diagnosed with pre-B ALL who was initially treated successfully with chemotherapy....
 

 Open Access DOI:10.23937/2469-5696/1410008

Thrombophilia: Demographics and Clinical Presentation in United Arab Emirates

Fatma H Sajwani and Moza A Khuzam

Article Type: Research Article | First Published: February 20, 2015

Thrombophilia is a group of disorders that increases the patient's risk of thrombosis. Inherited causes of thrombophilia are challenging to diagnose and once diagnosed may subject the patient to prolonged treatment. The extent of the condition is not well established in UAE and data on prevalence and demographics are lacking. This study aimed at setting a baseline data on the prevalence, demographics and clinical presentation of thrombophilia in ...
 

 Open Access DOI:10.23937/2469-5696/1410007

HemoCue versus Complete Blood Count for Hemoglobin Measurement in Adults with Vaso-occlusive Crisis due to Sickle Cell Disease

Michael Bursey, Kane Curtis, Robert Gibson, Hongyan Xu and Matthew Lyon

Article Type: Research Article | First Published: February 17, 2015

Hemoglobin (Hgb) measurement is an important risk-stratification tool for patients presenting to the Emergency Department with vaso-occlusive crisis (VOC) from sickle cell disease (SCD). Point-of- care (POC) Hgb testing such as the HemoCue device decreases time to identification of significant anemia. However, there are no studies evaluating the accuracy of HemoCue testing in patients with SCD and VOC. The purpose of this study was to evaluate th...
 

 Open Access DOI:10.23937/2469-5696/1410006

The Study of the Mechanism of Action of the Newly Synthesized Direct Anticoagulant of Thiazoline Ammonium -4-Chlorophenyl-2-Hydroxy-4-Oxo-2-Butenoate

Starkova AV, Syropyatov B Ya, Sobin FV and Pulina NA

Article Type: Case Report | First Published: February 08, 2015

The aim of this research is to study the mechanism of action of the newly synthesized substance - Thiazoline Ammonium 4-Chlorophenyl-2-Hydroxy-4-Oxo-2-Butenoate (FS-169), which possesses the direct anticoagulant activity. The research was conducted with the use of 'АPG4-02-P' coagulometer. For the purposes of the study the rabbit plasma was used. The results show that FS-169 effectively changes Partial thromboplastin time and prothrombin ti...
 

 Open Access DOI:10.23937/2469-5696/1410005

A Case of Localized Neuroblastoma in Caffey Disease, with Early and Uncommon Progression

Manuela Pagano, Chiara Galletto, Maurizio Bianchi and Franca Fagioli

Article Type: Case Report | First Published: January 21, 2015

Background: Caffey disease is a rare syndrome caused by mutation in the alpha-1 collagen type I gene, not described in literature as a predisposing condition to cancer development. Observation: We report a case of a 6-years-old female diagnosed with Caffey disease that developed a localized neuroblastoma. The patient had a poor clinical and radiological response with unusual disease dissemination and progression until death. Conclusion: The case ...
 

 Open Access DOI:10.23937/2469-5696/1410004

Diverse Genotype Presentation of the Saudi-Type Poly A Signal Mutation (αTsaudiα) in the Population of Bahrain

Nabeel Al Moamen, Fawzia Mahdi, Ahmed Thabet, Rugaya Abbas, Ebtihal Salman and Ahmed Al Alawi

Article Type: Letter to Editor | First Published: January 15, 2015

A total of 1187 patients with α-thalassemia phenotype presentation have been recruited for this investigation. Preliminary diagnosis of α-thalassemia was based on low hematological indices (MCV and MCH) of the red blood cells and/or persistently low hemoglobin levels, along with low or normal levels of HbA2 and absence of iron deficiency. Th molecular diagnosis of α-thalassemia was established by using a commercially available ^...
 

 Open Access DOI:10.23937/2469-5696/1410003

Lenalidomide as a Steroid Sparing Agent in a Myelodysplastic Syndrome Patient with Refractory Sweet Syndrome

Chakra P Chaulagain and Kenneth B Miller

Article Type: Case Report | First Published: December 22, 2014

Malignancy associated Sweet syndrome (acute febrile neutrophilic dermatosis) accounts for approximately 20% of all cases of Sweet syndrome and is characterized by painful, erythematous inflammatory papules and nodules that can precede, coincide or follow malignancies with predilection for hematologic malignancies. Corticosteroids are the cornerstone of treatment with exquisite response which has made many clinicians to include steroid responsiven...
 

 Open Access DOI:10.23937/2469-5696/1410002

Pharmacological Treatment may Impair Mineral Status in Blood

Joanna Suliburska

Article Type: Editorial | First Published: July 31, 2014

Some medicines may interact with mineral, with the result that changes occur in the concentration of minerals and other blood parameters that are associated with mineral status. Interpretation of the results of morphological and biochemical blood analyses therefore needs to take into account the drugs used by patients....
 

 Open Access DOI:10.23937/2469-5696/1410001

The Progress of Oncolytic Reovirus in Hematologic Malignancies: Can we Combat Blood Cancer with the Cold?

Jun Gong

Article Type: Editorial | First Published: July 30, 2014

Oncolytic reovirus continues to pick up momentum as a novel agent in the treatment of cancer. Since the initial discovery of the virus' tendency to preferentially replicate in transformed cell lines from studies in the late 1970s, reovirus has rapidly progressed from preclinical to clinical trials evaluating its efficacy across a spectrum of malignancies, including hematologic....

Editor-in-chief


ClinMed International Library

3
2
2
2

Articles Published

All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.

Contact our editorial office

Editors' Picks

Can Genetic Testing Provide Information to Develop Customized Nutrigenomic..
Pubmed ID:26225358 | PMC ID:PMC4516390
Acute Ovarian Insufficiency and Uterine Infarction Following Uterine Artery..
Pubmed ID:26523290 | PMC ID:PMC4623578
Challenges of Fertility Sparing Ovarian Surgery Imposed by Krukenberg..
Pubmed ID:26366440 | PMC ID:PMC4563814
Ultra-High Resolution Optical Coherence Tomography Imaging of Unilateral..
Pubmed ID:27398405 | PMC ID:PMC4936830
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant)..
Pubmed ID:29034323 | PMC ID:PMC5638455
Titanates and Titanate-Metal Compounds in Biological Contexts..
Pubmed ID:26430701 | PMC ID:PMC4587770
MyHEART: A Non Randomized Feasibility Study of a Young Adult..
Pubmed ID:28191544 | PMC ID:PMC5300088
Exenatide Effects on Cardiometabolic Risk and Weight in Adolescents..
Pubmed ID:27182560 | PMC ID:PMC4864000
A New Animal Model to Study Endogenous Cardiotonic Steroids and the Progression..
Pubmed ID:26457335 | PMC ID:PMC4599712
Common Genetic Variation in Circadian Rhythm Genes and Risk of..
Pubmed ID:26807442 | PMC ID:PMC4722961
Active Hexose Correlated Compound Activates Immune Function to Decrease..
Pubmed ID:27790645 | PMC ID:PMC5079436
The Extraction, Anticancer Effect, Bioavailability, and..
Pubmed ID:27790646 | PMC ID:PMC5079443
Kyphosis and Sleep Characteristics in Older Persons: The Rancho..
Pubmed ID:28480455 | PMC ID:PMC5419044
Suppression of Experimental Arthritis through AMP-Activated Protein..
Pubmed ID:26120598 | PMC ID:PMC4479345
Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of..
Pubmed ID:27110599 | PMC ID:PMC4841619
Elder Mistreatment and its Subtypes across Different Sociodemographic and..
Pubmed ID:26973979 | PMC ID:PMC4786076
Balance and its Clinical Assessment in Older Adults - A Review..
Pubmed ID:26942231 | PMC ID:PMC4773046
Caregiver Abuse of Chicago Chinese Older Adults in a Community..
Pubmed ID:27606358 | PMC ID:PMC5008847
The Relationship of Older Adults' Physical Pain to Depression and..
Pubmed ID:27642644 | PMC ID:PMC5023019
Sphingosine 1-Phosphate Receptor 2 Regulates the Migration,..
Pubmed ID:27275017 | PMC ID:PMC4888913
Mammary Epithelial Cell Lineage Analysis via the Lyon's Hypothesis..
Pubmed ID:27453956 | PMC ID:PMC4957014
Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell..
Pubmed ID:27570841 | PMC ID:PMC4996274
Long-Term Function, Pain and Medication Use Outcomes of Radiofrequency..
Pubmed ID:26005713 | PMC ID:PMC4440581
Caspase Cleaved Tau in Alzheimer's Disease: A Therapeutic Target..
Pubmed ID:25639474 | PMC ID:PMC4308811
Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?..
Pubmed ID:26550607 | PMC ID:PMC4634668
Differences in ME and CFS Symptomology in Patients with Normal and..
Pubmed ID:28713856 | PMC ID:PMC5510614
Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive..
Pubmed ID:26005715 | PMC ID:PMC4440485
A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1..
Pubmed ID:26688830 | PMC ID:PMC4682050
Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced..
Pubmed ID:26726315 | PMC ID:PMC4697745
Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate..
Pubmed ID:26878064 | PMC ID:PMC4751054
Electron Microscopic Analysis of Silicate and Calcium Particles..
Pubmed ID:27158665 | PMC ID:PMC4858188
Effects of chest physical therapy in patients with non-tuberculous mycobacteria
Pubmed ID:28804763 | PMC ID:PMC5552049
A Community-Based Exercise and Support Group Program Improves Quality..
Pubmed ID:26640827 | PMC ID:PMC4667740
Four Weeks of Balance Training Does Not Affect Ankle Joint Stiffness in Subjects..
Pubmed ID:27642647 | PMC ID:PMC5025258
Social Ecology and Diabetes Self-Management among Pacific Islanders..
Pubmed ID:28736764 | PMC ID:PMC4516390
Examining Characteristics of Hospitalizations in Heart Failure Patients: Results..
Pubmed ID:28736765 | PMC ID:PMC5517048